Illumina(ILMN) ZACKS·2024-11-04 23:56分组1 - Illumina reported quarterly earnings of $1.14 per share, exceeding the Zacks Consensus Estimate of $0.87 per share, and showing a significant increase from $0.33 per share a year ago, resulting in an earnings surprise of 31.03% [1] - The company achieved revenues of $1.08 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.48%, although this represents a decline from year-ago revenues of $1.12 billion [2] - Illumina has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance in earnings [2] 分组2 - The stock has underperformed the market with a gain of about 7.6% since the beginning of the year, compared to the S&P 500's gain of 20.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.93 on revenues of $1.1 billion, and for the current fiscal year, it is $3.62 on revenues of $4.34 billion [7] - The Medical - Biomedical and Genetics industry, to which Illumina belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook for the sector [8]